医薬品受託製造の世界市場：市場規模・シェア・動向分析 (製品別、医薬品別、サービス別、事業規模別、ワークフロー別、用途別、最終用途別、企業規模別、地域別)、セグメント別予測 (2025年～2030年)

医薬品受託製造市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医薬品受託製造市場規模は2030年までに2,245億1,000万米ドルに達する見込みです。

同市場は2025年から2030年にかけてCAGR 9.84％で成長すると予測されています。同市場の成長機会は、コスト効率、受託製造施設を活用して生産を合理化できること、コアコンピタンスに集中できる機会など、製薬企業にもたらされるメリットに起因しています。さらに、生物製剤、バイオシミラー、高活性医薬品成分（HPAPI）、個別化医療に対する需要の高まりが市場を牽引しています。

製薬企業の新製品イノベーションへの進出は、臨床試験、包装、規制遵守のための製造受託機関（CMO）サービスの需要増加につながっています。連続製造、自動化、AIによるプロセス最適化など、CMO間の技術統合が医薬品製造をさらに促進しています。これらの技術革新は効率を高め、無駄を省き、製品の品質と標準を向上させる。

CMOプロバイダーは、企業がFDA、EMA、ICHの規制要件を満たす上で重要な役割を果たしているため、医薬品受託製造業界は予測期間中も継続的な成長が見込まれています。さらに、ブランド医薬品とジェネリック医薬品の両方の需要が高まっていることも、医薬品受託製造業界の拡大に大きく寄与しています。様々なジェネリック医薬品が特許満了を迎える中、製薬企業はこの需要に応えるために新たなジェネリック医薬品を開発しています。したがって、こうした製薬企業の多くは、市場のニーズを効率的かつ効果的に満たすためにCMOサービスに依存しています。

さらに、規制は医薬品にとって重要な要因のひとつであり、医薬品受託製造の需要を煽っています。FDAは市場における医薬品の安全性と効率を確保する上で極めて重要な役割を果たしています。同様に、戦略的パートナーシップや製品上市の加速も市場成長を後押ししています。例えば、2024年12月、ロンザは、革新的なカプセル企業独自の開発・製造ニーズをサポートするため、経口投与生物学的製剤のサービス提供拡大について言及しました。この製品の発売により、患者はバイオアベイラビリティの課題を軽減するための革新的な送達ソリューションを検討することができるようになります。

医薬品受託製造市場：分析概要

• 2024年の市場シェアはAPI製造セグメントが70.68%で圧倒的でした。このセグメントの成長は、HPAPI生産の増加、連続的なAPI製造に対する需要の高まり、FDAによる市場認可の拡大、新製品の発売などに起因します。
• これは、ジェネリック医薬品、特殊医薬品、HPAPIの需要が増加していること、医薬品の技術革新が進み、CMOの効率性、拡張性、規制遵守の要件が強化され、市場の成長をさらに促進していることに起因しています。
• 慢性疾患の増加、特許切れの増加、コスト効率の高い医薬品への需要の高まりにより、2024年にはジェネリック医薬品分野が市場を独占しました。
• 事業規模別では、バッチ製剤部門が市場を独占しました。2024年には88.88%を占め、バッチ生産などのさまざまな利点と、運用コスト削減のための主要なサポートに起因しています。
• 商業用セグメントが2024年に市場を独占しました。このセグメントの成長は、病気の治療に役立つ様々な製品の発売が増加していることに起因しています。
• 用途別では、がん領域が2024年に最大の市場シェアを占めました。このセグメントは、がん罹患率の増加と新薬要件によって牽引されています。
• 製薬企業セグメントは、最終用途に基づいて2024年に最大の市場シェアを占めました。製薬企業は、コスト削減、拡張性の向上、市場投入までの時間短縮のために受託製造を活用しています。CMOは、原薬合成、製剤化、法規制遵守に関する専門知識を提供します。また、アウトソーシングにより、高度な技術、柔軟な生産能力、最適化された世界サプライチェーンを利用できます。
• 2024年には、従業員の力、設備、ベンチャー資金の増加により、小規模企業が市場を独占します。
• 予測期間中、アジア太平洋地域がCAGR 10.80%と最速の成長率を記録する見込み。日本、中国、インドなどの国々で製薬企業や製造受託機関の数が増加しているため、アジア太平洋地域は予測期間中に急成長を遂げる可能性が高いです。さらに、米国と比較して低コストで熟練した労働力をこの地域で利用できることも、市場成長を促進すると予想される要因です。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 医薬品受託製造市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 医薬品受託製造市場：分析ツール
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 医薬品受託製造市場：サービス別の推定・動向分析

• 医薬品受託製造市場、サービス別：セグメントダッシュボード
• 医薬品受託製造市場、サービス別：変動分析
• サービス別 (2018～2030年)
• API製造
• 完成医薬品製造
  • 経口固形物
  • 液体
  • 話題
  • その他
• 梱包サービス

第5章 医薬品受託製造市場：製品別の推定・動向分析

• 医薬品受託製造市場、製品別：セグメントダッシュボード
• 医薬品受託製造市場、製品別：変動分析
• 製品別 (2018～2030年)
• 小分子
• 生物学的製剤
  • モノクローナル抗体
  • ワクチン
  • 組み換えタンパク質
  • その他

第6章 医薬品受託製造市場：医薬品別の推定・動向分析

• 医薬品受託製造市場、医薬品別：セグメントダッシュボード
• 医薬品受託製造市場、医薬品別：変動分析
• 薬物別 (2018～2030年)
• ジェネリック
• ブランド

第7章 医薬品受託製造市場：事業規模別の推定・動向分析

• 医薬品受託製造市場、事業規模別：セグメントダッシュボード
• 医薬品受託製造市場、事業規模別：変動分析
• 事業規模別 (2018～2030年)
• バッチ
• 連続

第8章 医薬品受託製造市場：ワークフロー別の推定・動向分析

• 医薬品受託製造市場、ワークフロー別：セグメントダッシュボード
• 医薬品受託製造市場、ワークフロー別：変動分析
• ワークフロー別 (2018～2030年)
• 臨床
  • 臨床市場 (2018～2030年)
• 商業
  • 商業市場 (2018～2030年)

第9章 医薬品受託製造市場：用途別の推定・動向分析

• 医薬品受託製造市場、用途別：セグメントダッシュボード
• 医薬品受託製造市場、用途別：変動分析
• 用途別 (2018～2030年)
• 腫瘍学
  • 腫瘍学市場 (2018～2030年)
• 感染症
  • 感染症市場 (2018～2030年)
• 神経疾患
  • 神経疾患市場 (2018～2030年)
• 心血管疾患
  • 心血管疾患市場 (2018～2030年)
• 代謝障害
  • 代謝障害市場 (2018～2030年)
• 自己免疫疾患
  • 自己免疫疾患市場 (2018～2030年)
• 呼吸器疾患
  • 呼吸器疾患市場 (2018～2030年)
• 眼科
  • 眼科市場 (2018～2030年)
• 消化器障害
  • 消化器疾患市場 (2018～2030年)
• ホルモン障害
  • ホルモン障害市場 (2018～2030年)
• 血液疾患
  • 血液疾患市場 (2018～2030年)
• その他
  • その他市場 (2018～2030年)

第10章 医薬品受託製造市場：最終用途別の推定・動向分析

• 医薬品受託製造市場、最終用途別：セグメントダッシュボード
• 医薬品受託製造市場、最終用途別：変動分析
• 最終用途別 (2018～2030年)
• 製薬企業
  • 製薬企業市場 (2018～2030年)
• バイオテクノロジー企業
  • バイオテクノロジー企業市場 (2018～2030年)

第11章 医薬品受託製造市場：企業規模別の推定・動向分析

• 医薬品受託製造市場、企業規模別：セグメントダッシュボード
• 医薬品受託製造市場、企業規模別：変動分析
• 企業規模別 (2018～2030年)
• 小規模企業
  • 小規模企業市場 (2018～2030年)
• 中規模企業
  • 中規模企業市場 (2018～2030年)
• 大企業
  • 大企業市場 (2018～2030年)

第12章 医薬品受託製造市場：地域別の推定・動向分析

• 市場シェア分析：地域別 (2024年・2030年)
• 市場ダッシュボード：地域別
• 世界市場のスナップショット：地域別
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第13章 競合情勢

• 市場参入企業の分類
• 企業市場シェア分析（2023/24年）
• 企業プロファイル
  • AbbVie Contract Manufacturing
  • Almac Group
  • Boehringer Ingelheim BioXcellence
  • Catalent
  • Dr. Reddy's Laboratories
  • Fareva
  • Fujifilm Diosynth Biotechnologies
  • Jubilant HollisterStier
  • Lonza Group
  • Patheon（Thermo Fisher Scientific）
  • Pfizer CentreOne
  • Prakruti Life Science
  • Recipharm
  • Samsung Biologics
  • Siegfried Holding AG
  • Vetter Pharma
  • WuXi AppTec

List of Tables

• Table. 1 List of Secondary Sources
• Table. 2 List of Abbreviations
• Table. 3 Global Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 4 Global Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 5 Global Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 6 Global Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 7 Global Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 8 Global Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 9 Global Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 10 Global Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 11 North America Pharmaceutical Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
• Table. 12 North America Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 13 North America Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 14 North America Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 15 North America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 16 North America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 17 North America Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 18 North America Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 19 North America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 20 U.S. Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 21 U.S. Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 22 U.S. Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 23 U.S. Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 24 U.S. Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 25 U.S. Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 26 U.S. Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 27 U.S. Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 28 Canada Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 29 Canada Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 30 Canada Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 31 Canada Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 32 Canada Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 33 Canada Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 34 Canada Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 35 Canada Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 36 Mexico Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 37 Mexico Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 38 Mexico Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 39 Mexico Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 40 Mexico Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 41 Mexico Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 42 Mexico Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 43 Mexico Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 44 Europe Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table. 45 Europe Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 46 Europe Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 47 Europe Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 48 Europe Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 49 Europe Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 50 Europe Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 51 Europe Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 52 Europe Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 53 UK Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 54 UK Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 55 UK Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 56 UK Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 57 UK Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 58 UK Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 59 UK Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 60 UK Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 61 Germany Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 62 Germany Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 63 Germany Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 64 Germany Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 65 Germany Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 66 Germany Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 67 Germany Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 68 Germany Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 69 France Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 70 France Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 71 France Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 72 France Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 73 France Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 74 France Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 75 France Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 76 France Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 77 Italy Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 78 Italy Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 79 Italy Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 80 Italy Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 81 Italy Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 82 Italy Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 83 Italy Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 84 Italy Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 85 Spain Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 86 Spain Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 87 Spain Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 88 Spain Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 89 Spain Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 90 Spain Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 91 Spain Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 92 Spain Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 93 Denmark Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 94 Denmark Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 95 Denmark Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 96 Denmark Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 97 Denmark Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 98 Denmark Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 99 Denmark Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 100 Denmark Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 101 Sweden Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 102 Sweden Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 103 Sweden Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 104 Sweden Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 105 Sweden Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 106 Sweden Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 107 Sweden Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 108 Sweden Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 109 Norway Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 110 Norway Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 111 Norway Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 112 Norway Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 113 Norway Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 114 Norway Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 115 Norway Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 116 Norway Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 117 Asia Pacific Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table. 118 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 119 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 120 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 121 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 122 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 123 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 124 Asia Pacific Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 125 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 126 Japan Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 127 Japan Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 128 Japan Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 129 Japan Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 130 Japan Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 131 Japan Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 132 Japan Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 133 Japan Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 134 China Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 135 China Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 136 China Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 137 China Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 138 China Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 139 China Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 140 China Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 141 China Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 142 India Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 143 India Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 144 India Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 145 India Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 146 India Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 147 India Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 148 India Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 149 India Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 150 Thailand Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 151 Thailand Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 152 Thailand Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 153 Thailand Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 154 Thailand Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 155 Thailand Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 156 Thailand Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 157 Thailand Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 158 South Korea Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 159 South Korea Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 160 South Korea Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 161 South Korea Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 162 South Korea Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 163 South Korea Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 164 South Korea Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 165 South Korea Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 166 Australia Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 167 Australia Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 168 Australia Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 169 Australia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 170 Australia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 171 Australia Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 172 Australia Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 173 Australia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 174 Latin America Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table. 175 Latin America Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 176 Latin America Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 177 Latin America Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 178 Latin America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 179 Latin America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 180 Latin America Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 181 Latin America Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 182 Latin America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 183 Brazil Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 184 Brazil Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 185 Brazil Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 186 Brazil Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 187 Brazil Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 188 Brazil Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 189 Brazil Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 190 Brazil Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 191 Argentina Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 192 Argentina Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 193 Argentina Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 194 Argentina Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 195 Argentina Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 196 Argentina Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 197 Argentina Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 198 Argentina Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 199 Middle East & Africa Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table. 200 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 201 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 202 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 203 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 204 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 205 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 206 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 207 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 208 South Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 209 South Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 210 South Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 211 South Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 212 South Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 213 South Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 214 South Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 215 South Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 216 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 217 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 218 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 219 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 220 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 221 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 222 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 223 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 224 UAE Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 225 UAE Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 226 UAE Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 227 UAE Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 228 UAE Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 229 UAE Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 230 UAE Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 231 UAE Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
• Table. 232 Kuwait Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table. 233 Kuwait Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table. 234 Kuwait Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
• Table. 235 Kuwait Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
• Table. 236 Kuwait Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
• Table. 237 Kuwait Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
• Table. 238 Kuwait Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table. 239 Kuwait Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 ((USD Million)
• Table. 240 Financial performance

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 Pharmaceutical Contract Manufacturing Market dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Pharmaceutical Contract Manufacturing Market: Service outlook and key takeaways
• Fig. 20 Pharmaceutical Contract Manufacturing Market: Service movement analysis
• Fig. 21 API manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Finished drug product manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Oral solids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Liquids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Topical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Packaging services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Pharmaceutical Contract Manufacturing Market: Product outlook and key takeaways
• Fig. 29 Pharmaceutical Contract Manufacturing Market: Product movement analysis
• Fig. 30 Small molecule market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Vaccines market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Recombinant proteins market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Pharmaceutical Contract Manufacturing Market: Drug outlook and key takeaways
• Fig. 37 Pharmaceutical Contract Manufacturing Market: Drug movement analysis
• Fig. 38 Generics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Branded market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Pharmaceutical Contract Manufacturing Market: Scale of operation outlook and key takeaways
• Fig. 41 Pharmaceutical Contract Manufacturing Market: Scale of operation movement analysis
• Fig. 42 Batch market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Continuous market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Pharmaceutical Contract Manufacturing Market: Workflow outlook and key takeaways
• Fig. 45 Pharmaceutical Contract Manufacturing Market: Workflow movement analysis
• Fig. 46 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Commercial market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Pharmaceutical Contract Manufacturing Market: Application outlook and key takeaways
• Fig. 49 Pharmaceutical Contract Manufacturing Market: Application movement analysis
• Fig. 50 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Cardiovascular disease market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Respiratory diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Hormonal disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Hematological disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Pharmaceutical Contract Manufacturing Market: End Use outlook and key takeaways
• Fig. 63 Pharmaceutical Contract Manufacturing Market: End Use movement analysis
• Fig. 64 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Pharmaceutical Contract Manufacturing Market: Company Size outlook and key takeaways
• Fig. 67 Pharmaceutical Contract Manufacturing Market: Company Size movement analysis
• Fig. 68 Small market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Medium market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Large market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Regional Marketplace: Key Takeaways
• Fig. 72 North America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 U.S. Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Canada Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 Mexico Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Europe Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 UK Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Germany Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 France Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 Italy Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Spain Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Denmark outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Sweden outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Norway outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Asia Pacific Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Key country dynamics
• Fig. 98 Japan Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Key country dynamics
• Fig. 100 China Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 101 Key country dynamics
• Fig. 102 India Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 103 Key country dynamics
• Fig. 104 Thailand Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 105 Key country dynamics
• Fig. 106 South Korea Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 107 Key country dynamics
• Fig. 108 Australia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 109 Latin America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 110 Key country dynamics
• Fig. 111 Brazil Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 112 Key country dynamics
• Fig. 113 Argentina Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 114 MEA Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 115 Key country dynamics
• Fig. 116 South Africa Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 117 Fig. Key country dynamics
• Fig. 118 Saudi Arabia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 119 Key country dynamics
• Fig. 120 UAE Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 121 Key country dynamics
• Fig. 122 Kuwait Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 123 Key company categorization
• Fig. 124 Service heat map analysis
• Fig. 125 Strategic framework

Pharmaceutical Contract Manufacturing Market Growth & Trends:

The global pharmaceutical contract manufacturing market size is expected to reach USD 224.51 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 9.84% from 2025 to 2030. Growth in the market can be attributed to benefits offered to pharmaceutical companies, such as cost efficiencies, the ability to leverage contract manufacturing facilities to streamline production, and the opportunity to focus on core competencies. In addition, the market is driven by the increasing demand for biologics, biosimilars, high-potency active pharmaceutical ingredients (HPAPIs), and personalized medicine.

The expansion of pharmaceutical companies into new product innovations has led to the increased demand for contract manufacturing organization (CMO) services for clinical trials, packaging, and regulatory compliance. Technological integrations among CMOs, such as continuous manufacturing, automation, and AI-driven process optimization, are further propelling pharmaceutical production. These innovations enhance efficiency, reduce waste, and improve product quality and standards.

The pharmaceutical contract manufacturing industry is expected to experience continued growth during the forecast period, as CMO providers play a crucial role in helping companies meet the regulatory requirements of the FDA, EMA, and ICH. Moreover, the growing demand for both branded and generic drugs is a significant factor in the expansion of the pharmaceutical contract manufacturing industry. As various generic drugs reach patent expiration, pharmaceutical companies are innovating new generic versions to meet this demand. Hence, many of these pharmaceutical companies are relying on CMO services to fulfill market needs efficiently and effectively.

In addition, regulation is one of the significant factors for pharmaceutical products that have fueled the demand for pharmaceutical contract manufacturing. The FDA plays a pivotal role in ensuring the safety and efficiency of pharmaceuticals in the market. Likewise, strategic partnerships and accelerating product launches drive market growth. For instance, in December 2024, Lonza mentioned the expansion of its service offering orally delivered biologic therapies to support innovative capsule companies' unique development and manufacturing needs. The product launch will help patients explore innovative delivery solutions to mitigate bioavailability challenges.

Pharmaceutical Contract Manufacturing Market Report Highlights:

• The API manufacturing segment dominated the market with a share of 70.68% in 2024. Growth in the segment can be attributed to increasing HPAPI production, rising demand for continuous API manufacturing, growing FDA approval for the market, and the launch of new products.
• Based on product, the small molecule segment held the largest market share in 2024, which is attributed to the increasing demand for generics, specialty drugs, and HPAPIs, and growing innovations of drugs have enhanced the requirement for CMO's efficiency, scalability, and regulatory compliance further driving the market growth.
• The generics segment dominated the market in 2024 owing to the increasing prevalence of chronic diseases, growing patent expirations, and rising demand for cost-efficient drugs.
• Based on scale of operation, the batch segment dominated the market. It accounted for 88.88% in 2024, attributing to various benefits such as batch production and major support for saving operational costs.
• The commercial segment dominated the market in 2024. Growth in this segment can be attributed to the increasing launch of various products that help treat diseases.
• The oncology segment held the largest market share in 2024 based on application. This segment is driven by increasing cancer incidences and new pharmaceutical drug requirements.
• The pharmaceutical companies segment held the largest market share in 2024 based on end-use. Pharmaceutical companies utilize contract manufacturing to lower costs, increase scalability, and speed up time-to-market. CMOs offer expertise in API synthesis, formulation, and regulatory compliance. In addition, outsourcing provides access to advanced technologies, flexible production capacity, and optimized global supply chains.
• The small company size segment dominated the market in 2024 due to increasing employee strengths, facilities, and venture funding.
• Asia Pacific is expected to register the fastest growth rate of 10.80% CAGR over the forecast period. Due to the rising number of pharmaceutical companies & contract manufacturing organizations in countries like Japan, China, and India, Asia Pacific will likely witness rapid growth over the estimated time. Furthermore, the availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Product
  • 1.2.3. Drug
  • 1.2.4. Scale of Operation
  • 1.2.5. Workflow
  • 1.2.6. Application
  • 1.2.7. End Use
  • 1.2.8. Company Size
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights

Chapter 3. Pharmaceutical Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technological Advancements
• 3.4. Clinical trials volume analysis (2024)
• 3.5. Pharmaceutical Contract Manufacturing Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Analysis
  • 3.5.2. PESTEL Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Contract Manufacturing Market: Service Estimates & Trend Analysis

• 4.1. Pharmaceutical Contract Manufacturing Market, By Service: Segment Dashboard
• 4.2. Pharmaceutical Contract Manufacturing Market, By Service: Movement Analysis
• 4.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030
• 4.4. API Manufacturing
  • 4.4.1. API Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Finished Drug Product Manufacturing
  • 4.5.1. Finished Drug Product Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Oral Solids
    • 4.5.2.1. Oral Solids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Liquids
    • 4.5.3.1. Liquids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Topical
    • 4.5.4.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Packaging Services
  • 4.6.1. Packaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Manufacturing Market: Product Estimates & Trend Analysis

• 5.1. Pharmaceutical Contract Manufacturing Market, By Product: Segment Dashboard
• 5.2. Pharmaceutical Contract Manufacturing Market, By Product: Movement Analysis
• 5.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030
• 5.4. Small Molecule
  • 5.4.1. Small Molecule Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Biologics
  • 5.5.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Monoclonal Antibodies
    • 5.5.2.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Vaccines
    • 5.5.3.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Recombinant Proteins
    • 5.5.4.1. Recombinant Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. Others
    • 5.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Manufacturing Market: Drug Estimates & Trend Analysis

• 6.1. Pharmaceutical Contract Manufacturing Market, By Drug: Segment Dashboard
• 6.2. Pharmaceutical Contract Manufacturing Market, By Drug: Movement Analysis
• 6.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Drug, 2018 - 2030
• 6.4. Generics
  • 6.4.1. Generics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Branded
  • 6.5.1. Branded Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis

• 7.1. Pharmaceutical Contract Manufacturing Market, By Scale of Operation: Segment Dashboard
• 7.2. Pharmaceutical Contract Manufacturing Market, By Scale of Operation: Movement Analysis
• 7.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Scale of Operation, 2018 - 2030
• 7.4. Batch
  • 7.4.1. Batch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Continuous
  • 7.5.1. Continuous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Pharmaceutical Contract Manufacturing Market: Workflow Estimates & Trend Analysis

• 8.1. Pharmaceutical Contract Manufacturing Market, By Workflow: Segment Dashboard
• 8.2. Pharmaceutical Contract Manufacturing Market, By Workflow: Movement Analysis
• 8.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Workflow, 2018 - 2030
• 8.4. Clinical
  • 8.4.1. Clinical Market, 2018 to 2030, (USD Million)
• 8.5. Commercial
  • 8.5.1. Commercial Market, 2018 to 2030, (USD Million)

Chapter 9. Pharmaceutical Contract Manufacturing Market: Application Estimates & Trend Analysis

• 9.1. Pharmaceutical Contract Manufacturing Market, By Application: Segment Dashboard
• 9.2. Pharmaceutical Contract Manufacturing Market, By Application: Movement Analysis
• 9.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Application, 2018 - 2030
• 9.4. Oncology
  • 9.4.1. Oncology Market, 2018 to 2030, (USD Million)
• 9.5. Infectious Diseases
  • 9.5.1. Infectious Diseases Market, 2018 to 2030, (USD Million)
• 9.6. Neurological Disorders
  • 9.6.1. Neurological Disorders Market, 2018 to 2030, (USD Million)
• 9.7. Cardiovascular Disease
  • 9.7.1. Cardiovascular Disease Market, 2018 to 2030, (USD Million)
• 9.8. Metabolic Disorders
  • 9.8.1. Metabolic Disorders Market, 2018 to 2030, (USD Million)
• 9.9. Autoimmune Diseases
  • 9.9.1. Autoimmune Diseases Market, 2018 to 2030, (USD Million)
• 9.10. Respiratory Diseases
  • 9.10.1. Respiratory Diseases Market, 2018 to 2030, (USD Million)
• 9.11. Ophthalmology
  • 9.11.1. Ophthalmology Market, 2018 to 2030, (USD Million)
• 9.12. Gastrointestinal Disorders
  • 9.12.1. Gastrointestinal Disorders Market, 2018 to 2030, (USD Million)
• 9.13. Hormonal Disorders
  • 9.13.1. Hormonal Disorders Market, 2018 to 2030, (USD Million)
• 9.14. Hematological Disorders
  • 9.14.1. Hematological Disorders Market, 2018 to 2030, (USD Million)
• 9.15. Others
  • 9.15.1. Others Market, 2018 to 2030, (USD Million)

Chapter 10. Pharmaceutical Contract Manufacturing Market: End Use Estimates & Trend Analysis

• 10.1. Pharmaceutical Contract Manufacturing Market, By End Use: Segment Dashboard
• 10.2. Pharmaceutical Contract Manufacturing Market, By End Use: Movement Analysis
• 10.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030
• 10.4. Pharmaceutical Companies
  • 10.4.1. Pharmaceutical Companies Market, 2018 to 2030, (USD Million)
• 10.5. Biotechnology Companies
  • 10.5.1. Biotechnology Companies Market, 2018 to 2030, (USD Million)

Chapter 11. Pharmaceutical Contract Manufacturing Market: Company Size Estimates & Trend Analysis

• 11.1. Pharmaceutical Contract Manufacturing Market, By Company Size: Segment Dashboard
• 11.2. Pharmaceutical Contract Manufacturing Market, By Company Size: Movement Analysis
• 11.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Company Size, 2018 - 2030
• 11.4. Small
  • 11.4.1. Small Market, 2018 to 2030, (USD Million)
• 11.5. Medium
  • 11.5.1. Medium Market, 2018 to 2030, (USD Million)
• 11.6. Large
  • 11.6.1. Large Market, 2018 to 2030, (USD Million)

Chapter 12. Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis

• 12.1. Regional Market Share Analysis, 2024 & 2030
• 12.2. Regional Market Dashboard
• 12.3. Global Regional Market Snapshot
• 12.4. North America
  • 12.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.4.2. U.S
    • 12.4.2.1. Key Country Dynamics
    • 12.4.2.2. Competitive Scenario
    • 12.4.2.3. Regulatory Framework
    • 12.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.4.3. Canada
    • 12.4.3.1. Key Country Dynamics
    • 12.4.3.2. Competitive Scenario
    • 12.4.3.3. Regulatory Framework
    • 12.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.4.4. Mexico
    • 12.4.4.1. Key Country Dynamics
    • 12.4.4.2. Competitive Scenario
    • 12.4.4.3. Regulatory Framework
    • 12.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 12.5. Europe
  • 12.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.2. UK
    • 12.5.2.1. Key Country Dynamics
    • 12.5.2.2. Competitive Scenario
    • 12.5.2.3. Regulatory Framework
    • 12.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.3. Germany
    • 12.5.3.1. Key Country Dynamics
    • 12.5.3.2. Competitive Scenario
    • 12.5.3.3. Regulatory Framework
    • 12.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.4. France
    • 12.5.4.1. Key Country Dynamics
    • 12.5.4.2. Competitive Scenario
    • 12.5.4.3. Regulatory Framework
    • 12.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.5. Italy
    • 12.5.5.1. Key Country Dynamics
    • 12.5.5.2. Competitive Scenario
    • 12.5.5.3. Regulatory Framework
    • 12.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.6. Spain
    • 12.5.6.1. Key Country Dynamics
    • 12.5.6.2. Competitive Scenario
    • 12.5.6.3. Regulatory Framework
    • 12.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.7. Denmark
    • 12.5.7.1. Key Country Dynamics
    • 12.5.7.2. Competitive Scenario
    • 12.5.7.3. Regulatory Framework
    • 12.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.8. Sweden
    • 12.5.8.1. Key Country Dynamics
    • 12.5.8.2. Competitive Scenario
    • 12.5.8.3. Regulatory Framework
    • 12.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5.9. Norway
    • 12.5.9.1. Key Country Dynamics
    • 12.5.9.2. Competitive Scenario
    • 12.5.9.3. Regulatory Framework
    • 12.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 12.6. Asia Pacific
  • 12.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6.2. Japan
    • 12.6.2.1. Key Country Dynamics
    • 12.6.2.2. Competitive Scenario
    • 12.6.2.3. Regulatory Framework
    • 12.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6.3. China
    • 12.6.3.1. Key Country Dynamics
    • 12.6.3.2. Competitive Scenario
    • 12.6.3.3. Regulatory Framework
    • 12.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6.4. India
    • 12.6.4.1. Key Country Dynamics
    • 12.6.4.2. Competitive Scenario
    • 12.6.4.3. Regulatory Framework
    • 12.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6.5. Thailand
    • 12.6.5.1. Key Country Dynamics
    • 12.6.5.2. Competitive Scenario
    • 12.6.5.3. Regulatory Framework
    • 12.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6.6. South Korea
    • 12.6.6.1. Key Country Dynamics
    • 12.6.6.2. Competitive Scenario
    • 12.6.6.3. Regulatory Framework
    • 12.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6.7. Australia
    • 12.6.7.1. Key Country Dynamics
    • 12.6.7.2. Competitive Scenario
    • 12.6.7.3. Regulatory Framework
    • 12.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 12.7. Latin America
  • 12.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.7.2. Brazil
    • 12.7.2.1. Key Country Dynamics
    • 12.7.2.2. Competitive Scenario
    • 12.7.2.3. Regulatory Framework
    • 12.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.7.3. Argentina
    • 12.7.3.1. Key Country Dynamics
    • 12.7.3.2. Competitive Scenario
    • 12.7.3.3. Regulatory Framework
    • 12.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 12.8. MEA
  • 12.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.8.2. South Africa
    • 12.8.2.1. Key Country Dynamics
    • 12.8.2.2. Competitive Scenario
    • 12.8.2.3. Regulatory Framework
    • 12.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.8.3. Saudi Arabia
    • 12.8.3.1. Key Country Dynamics
    • 12.8.3.2. Competitive Scenario
    • 12.8.3.3. Regulatory Framework
    • 12.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.8.4. UAE
    • 12.8.4.1. Key Country Dynamics
    • 12.8.4.2. Competitive Scenario
    • 12.8.4.3. Regulatory Framework
    • 12.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.8.5. Kuwait
    • 12.8.5.1. Key Country Dynamics
    • 12.8.5.2. Competitive Scenario
    • 12.8.5.3. Regulatory Framework
    • 12.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 13. Competitive Landscape

• 13.1. Market Participant Categorization
• 13.2. Company Market Share Analysis, 2023/24
• 13.3. Company Profiles
  • 13.3.1. AbbVie Contract Manufacturing
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Financial Performance
    • 13.3.1.3. Service Benchmarking
    • 13.3.1.4. Strategic Initiatives
  • 13.3.2. Almac Group
    • 13.3.2.1. Company Overview
    • 13.3.2.2. Financial Performance
    • 13.3.2.3. Service Benchmarking
    • 13.3.2.4. Strategic Initiatives
  • 13.3.3. Boehringer Ingelheim BioXcellence
    • 13.3.3.1. Company Overview
    • 13.3.3.2. Financial Performance
    • 13.3.3.3. Service Benchmarking
    • 13.3.3.4. Strategic Initiatives
  • 13.3.4. Catalent
    • 13.3.4.1. Company Overview
    • 13.3.4.2. Financial Performance
    • 13.3.4.3. Service Benchmarking
    • 13.3.4.4. Strategic Initiatives
  • 13.3.5. Dr. Reddy's Laboratories
    • 13.3.5.1. Company Overview
    • 13.3.5.2. Financial Performance
    • 13.3.5.3. Service Benchmarking
    • 13.3.5.4. Strategic Initiatives
  • 13.3.6. Fareva
    • 13.3.6.1. Company Overview
    • 13.3.6.2. Financial Performance
    • 13.3.6.3. Service Benchmarking
    • 13.3.6.4. Strategic Initiatives
  • 13.3.7. Fujifilm Diosynth Biotechnologies
    • 13.3.7.1. Company Overview
    • 13.3.7.2. Financial Performance
    • 13.3.7.3. Service Benchmarking
    • 13.3.7.4. Strategic Initiatives
  • 13.3.8. Jubilant HollisterStier
    • 13.3.8.1. Company Overview
    • 13.3.8.2. Financial Performance
    • 13.3.8.3. Service Benchmarking
    • 13.3.8.4. Strategic Initiatives
  • 13.3.9. Lonza Group
    • 13.3.9.1. Company Overview
    • 13.3.9.2. Financial Performance
    • 13.3.9.3. Service Benchmarking
    • 13.3.9.4. Strategic Initiatives
  • 13.3.10. Patheon (Thermo Fisher Scientific)
    • 13.3.10.1. Company Overview
    • 13.3.10.2. Financial Performance
    • 13.3.10.3. Service Benchmarking
    • 13.3.10.4. Strategic Initiatives
  • 13.3.11. Pfizer CentreOne
    • 13.3.11.1. Company Overview
    • 13.3.11.2. Financial Performance
    • 13.3.11.3. Service Benchmarking
    • 13.3.11.4. Strategic Initiatives
  • 13.3.12. Prakruti Life Science
    • 13.3.12.1. Company Overview
    • 13.3.12.2. Financial Performance
    • 13.3.12.3. Service Benchmarking
    • 13.3.12.4. Strategic Initiatives
  • 13.3.13. Recipharm
    • 13.3.13.1. Company Overview
    • 13.3.13.2. Financial Performance
    • 13.3.13.3. Service Benchmarking
    • 13.3.13.4. Strategic Initiatives
  • 13.3.14. Samsung Biologics
    • 13.3.14.1. Company Overview
    • 13.3.14.2. Financial Performance
    • 13.3.14.3. Service Benchmarking
    • 13.3.14.4. Strategic Initiatives
  • 13.3.15. Siegfried Holding AG
    • 13.3.15.1. Company Overview
    • 13.3.15.2. Financial Performance
    • 13.3.15.3. Service Benchmarking
    • 13.3.15.4. Strategic Initiatives
  • 13.3.16. Vetter Pharma
    • 13.3.16.1. Company Overview
    • 13.3.16.2. Financial Performance
    • 13.3.16.3. Service Benchmarking
    • 13.3.16.4. Strategic Initiatives
  • 13.3.17. WuXi AppTec
    • 13.3.17.1. Company Overview
    • 13.3.17.2. Financial Performance
    • 13.3.17.3. Service Benchmarking
    • 13.3.17.4. Strategic Initiatives